Yatindra M. Joshi, Ph.D., is Vice President and Head of US and Latain America Generics R&D at Teva Pharmaceuticals, North Wales, PA. His interest/expertise are in dosage form design, application of statistical models for formulation & process optimization, scale-up, validation, drug delivery research, streamlining and accelerating drug development process, improving efficiency through robotics and automation, achieving organizational excellence, and building high performance organization. He has authored 29 publications and has 19 patents. He has lectured extensively on QbD, drug delivery, pharmaceutical education, and forward looking topics like Pharma 2020. He received his BS and MS degrees in Chemistry from Delhi University, Delhi, India, Ph.D. in Chemistry from Dalhousie University, Halifax, NS, Canada, and MBA from the Wharton School of Business, University of Pennsylvania. He has 26 years of experience in the pharmaceutical industry. Prior to joining Teva Pharmaceuticals has worked with Novartis Pharmaceuticals, Gensia Inc., and Bristol-Myers Squibb.